New Journal Website is available at:

Published by: Kowsar

Polymorphisms in NOS3, MTHFR, APOB and TNF-α Genes and Risk of Coronary Atherosclerotic Lesions in Iranian Patients

Mohammad Mehdi Heidari 1 , * , Mehri Khatami 1 , Mehdi Hadadzadeh 2 , Mahbobeh Kazemi 1 , Sahar Mahamed 1 , Pegah Malekzadeh 3 and Massomeh Mirjalili 1
Authors Information
1 Department of Biology, Faculty of Science, Yazd University, Yazd, IR Iran
2 Department of Cardiac Surgery, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
3 Department of Biology, Ashkezar Branch, Islamic Azad University, Ashkezar, IR Iran
Article information
  • Research in Cardiovascular Medicine: February 2016, 5 (1); e29134
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: April 8, 2015
  • Revised: July 7, 2015
  • Accepted: July 14, 2015
  • DOI: 10.5812/cardiovascmed.29134

To Cite: Heidari M M, Khatami M, Hadadzadeh M, Kazemi M, Mahamed S, et al. Polymorphisms in NOS3, MTHFR, APOB and TNF-α Genes and Risk of Coronary Atherosclerotic Lesions in Iranian Patients, Res Cardiovasc Med. 2016 ;5(1):e29134. doi: 10.5812/cardiovascmed.29134.

Copyright: Copyright © 2016, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Davies H. Atherogenesis and the coronary arteries of childhood. Int J Cardiol. 1990; 28(3): 283-91[PubMed]
  • 2. Lefkou E, Fragakis N, Ioannidou E, Bounda A, Theodoridou S, Klonizakis P, et al. Increased levels of proinflammatory cytokines in children with family history of coronary artery disease. Clin Cardiol. 2010; 33(4)-10[DOI][PubMed]
  • 3. Kaprio J, Norio R, Pesonen E, Sarna S. Intimal thickening of the coronary arteries in infants in relation to family history of coronary artery disease. Circulation. 1993; 87(6): 1960-8[PubMed]
  • 4. O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011; 365(22): 2098-109[DOI][PubMed]
  • 5. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem. 2003; 49(3): 389-95[PubMed]
  • 6. Yang Y, Du K, Liu Z, Lu X. Endothelial nitric oxide synthase (eNOS) 4b/a gene polymorphisms and coronary artery disease: evidence from a meta-analysis. Int J Mol Sci. 2014; 15(5): 7987-8003[DOI][PubMed]
  • 7. Kayhan FE, Koldemir M, Cagatay P, Ciftci C, Susleyici-Duman B. Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension. Diabetes Metab Syndr. 2013; 7(1): 12-6[DOI][PubMed]
  • 8. Wolff B, Grabe HJ, Schluter C, Popowski K, Volzke H, Ludemann J, et al. Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J Hypertens. 2005; 23(7): 1361-6[PubMed]
  • 9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10(1): 111-3[DOI][PubMed]
  • 10. Saffari B, Senemar S, Karimi M, Bahari M, Jooyan N, Yavarian M. An MTHFR variant, plasma homocysteine levels and late-onset coronary artery disease in subjects from southern Iran. Pak J Biol Sci. 2013; 16(16): 788-95[PubMed]
  • 11. Neto AI, Moura JJ, Persuhn DC. Frequency of MTHFR G1793A polymorphism in individuals with early coronary artery disease: cross-sectional study. Sao Paulo Med J. 2013; 131(5): 296-300[DOI][PubMed]
  • 12. Yigit S, Karakus N, Inanir A. Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy. Mol Vis. 2013; 19: 1626-30[PubMed]
  • 13. Raj R, Bhatti JS, Badada SK, Ramteke PW. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM). Diabetes Metab Res Rev. 2014; [DOI][PubMed]
  • 14. Gallegos-Arreola MP, Valdez Y, Zuniga-Corona M, Figuera LE, Arnaud-Lopez L, Robles-Cervantes JA, et al. Association between the Xba I polymorphism of APOB gene and plasma lipid level in Mexican patients with coronary artery disease. Asia Pac J Clin Nutr. 2012; 21(2): 312-8[PubMed]
  • 15. Bigdeli MR, Hajizadeh S, Rahnama M, Khoshbaten A, Heidarianpoor A. The Effect of Preconditioning with Prolonged and Intermittent Normobaric‎Hyperoxia on Upregulating TNF-α Converting Enzyme and Increasing Serum ‎TNF-α Level in Male Rats. Trauma Mon. 2007; 12(3): 197-208
  • 16. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000; 101(18): 2149-53[PubMed]
  • 17. Heidari MM, Foruzannia SK, Khatami M, Hadadzadeh M, Emami Meybodi M. Apolipoprotein e gene polymorphism in Iranian coronary atherosclerosis patients candidate for coronary artery bypass graft. Iran J Basic Med Sci. 2013; 16(7): 841-4[PubMed]
  • 18. Zamani M, Aleyasin A, Fakhrzadeh H, Kiavar M, Raoufzadeh S, Larijani B, et al. Heme Oxigenase 2 Gene Polymorphisms as Genetic Risk Factor in Atherosclerosis in Iranian Patients. Iran Red Crescent Med J. 2010; 2010(5): 559-63
  • 19. Salonen R, Nyyssonen K, Porkkala E, Rummukainen J, Belder R, Park JS, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. 1995; 92(7): 1758-64[PubMed]
  • 20. Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res. 2007; 73(2): 326-40[DOI][PubMed]
  • 21. Napoli C, Ignarro LJ. Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol. 2007; 60(4): 341-4[DOI][PubMed]
  • 22. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol. 2006; 164(10): 921-35[DOI][PubMed]
  • 23. Lamblin N, Cuilleret FJ, Helbecque N, Dallongeville J, Lablanche JM, Amouyel P, et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc Disord. 2005; 5: 27[DOI][PubMed]
  • 24. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, Henrion D, et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation. 1999; 99(24): 3096-8[PubMed]
  • 25. Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, et al. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart. 2002; 87(6): 525-8[PubMed]
  • 26. Fletcher O, Kessling AM. MTHFR association with arteriosclerotic vascular disease? Hum Genet. 1998; 103(1): 11-21[PubMed]
  • 27. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol. 2000; 13(1): 20-33[PubMed]
  • 28. Brousseau T, Arveiler D, Cambou JP, Evans AE, Luc G, Fruchart JC, et al. Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Temoins de l'Infarctus du Myocarde. Atherosclerosis. 1995; 116(2): 269-71[PubMed]
  • 29. Sabbagh AS, Daher RT, Otrock ZK, Khalek RN, Zaatari GS, Mahfouz RA. ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature. Mol Biol Rep. 2007; 34(4): 267-70[DOI][PubMed]
  • 30. Zakharova FM, Damgaard D, Mandelshtam MY, Golubkov VI, Nissen PH, Nilsen GG, et al. Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia. BMC Med Genet. 2005; 6: 6[DOI][PubMed]
  • 31. Sozen MM, Whittall R, Oner C, Tokatli A, Kalkanoglu HS, Dursun A, et al. The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis. 2005; 180(1): 63-71[DOI][PubMed]
  • 32. Fard-Esfahani P, Khatami S, Zeinali C, Taghikhani M, Allahyari M. A modified conformation sensitive gel electrophoresis (CSGE) method for rapid and accurate detection of low density lipoprotein (LDL) receptor gene mutations in Familial Hypercholesterolemia. Clin Biochem. 2005; 38(6): 579-83[DOI][PubMed]
  • 33. Farrokhi E, Shayesteh F, Asadi Mobarakeh S, Roghani Dehkordi F, Ghatreh Samani K, Hashemzadeh Chaleshtori M. Molecular characterization of Iranian patients with possible familial hypercholesterolemia. Indian J Clin Biochem. 2011; 26(3): 244-8[DOI][PubMed]
  • 34. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, et al. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis. 2003; 167(2): 257-64[PubMed]
  • 35. Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, et al. Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB J. 2005; 19(14): 1998-2004[DOI][PubMed]
  • 36. Cho HC, Yu G, Lee MY, Kim HS, Shin DH, Kim YN. TNF-alpha polymorphisms and coronary artery disease: association study in the Korean population. Cytokine. 2013; 62(1): 104-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader